Authors’ Reply: Histopathologic Outcomes after Transarterial Chemoembolization and Transarterial Radioembolization
- 23 September 2025
- journal article
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 37 (3) , 107852
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- A prospective randomized controlled trial of selective transarterial chemoembolization using drug-eluting beads loaded with epirubicin versus selective conventional transarterial chemoembolization using epirubicin-lipiodol for hepatocellular carcinoma: The JIVROSG-1302 PRESIDENT study.Journal of Clinical Oncology, 2020
- Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinomaBritish Journal of Cancer, 2014
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V StudyCardioVascular and Interventional Radiology, 2009
- Ultraselective Transcatheter Arterial Chemoembolization with a 2-F Tip Microcatheter for Small Hepatocellular Carcinomas: Relationship Between Local Tumor Recurrence and Visualization of the Portal Vein with Iodized OilJournal of Vascular and Interventional Radiology, 2007